Cytokine production in patients with tuberculous pericarditis

International Journal of Tuberculosis and Lung Disease

Volumn 6, Issue 5, 2002, Pages 439-446

  Burgess, L J ^a   Reuter, H ^a   Carstens, M E ^a   Taljaard, J J F ^a   Doubell, A F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Cytokines; IFN ; TNF ; Tuberculous pericarditis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE BIOPSY; HUMAN; KLEBSIELLA PNEUMONIAE; LUNG TUMOR; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALMONELLA; SOUTH AFRICA; SPUTUM SMEAR; STAPHYLOCOCCUS AUREUS; TH1 CELL; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; MALE; PERICARDIOCENTESIS; PERICARDITIS, TUBERCULOUS; PERICARDIUM; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036254764     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Tuberculosis in patients with human immunodeficiency virus infection
2. Impact of HIV on tuberculosis in sub-Saharan Africa: A regional perspective
3. Cytokine production at the site of disease in human tuberculosis
4. Radiographic abnormalities in tuberculosis and risk of co-existing human immunodeficiency virus infection: Methods and preliminary results from Bujumbura, Burundi
5. Recent experience with tuberculous pericarditis
6. Tuberculosis in patients with human immunodeficiency virus infection
7. Tuberculosis in patients with acquired immunodeficiency syndrome
8. Tuberculous pericarditis
9. Infectious pericarditis
10. Experimental pleural effusion as a manifestation of delayed hypersensitivity to tuberculin PPD
11. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy
12. Lymphocyte subpopulations, activation phenotypes and spontaneous proliferation in tuberculous pleural effusions
13. High levels of interferon gamma in tuberculous pleurisy
14. Immunobiology of pleural inflammation: Potential implications for pathogenesis, diagnosis and therapy
15. Operative and pathological findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculosis
16. Lymphocyte proliferation and gamma-interferon production after in vitro stimulation with PPD: Differences between tuberculous and nontuberculous pleurisy in patients with positive tuberculin test
17. Gamma delta T-lymphocytes in human tuberculosis
18. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme and interferon gamma
19. Interferon-γ in 388 immunocompromised and immunocompetent patients for diagnosing pleural tuberculosis
20. Pleural fluid interferon-γ in tuberculous and rheumaroid pleurisy
21. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion
22. Cellular resistance to infection
23. The effect of anti-lymphocyte globulin on cell-mediated resistance to infection
24. Requirement of thymus (T) lymphocytes for resistance to Listeriosis
25. Independent regulation of tumour necrosis factor and lymphotoxin production by human peripheral lymphocytes
26. An endotoxin-induced serm factor that causes necrosis of tumours
27. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection
28. Macrophage accumulation, division and digestive and microcidal capacities in the tuberculous lesions II. Rate at which mononuclear cells enter and divide in primary BCG lesions and those of reinfection
29. Overlapping pattern of activation of human endothelial cells by interleukin 1, tumour necrosis factor and immune interferon
30. Local production of tumour necrosis factor and IFN-gamma in tuberculous pleurisy
31. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor
32. Additive effects of interleukin 1 and tumour necrosis factor-a on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells
33. Tumour necrosis factor/cachetin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor
34. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
35. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induce by itself, γ-interferon and interleukin 1
36. Interferon γ and lymphotoxin of tumour necrosis factor act synergistically to induce macrophage killing of tumour cells and schistosomula of Schistosoma mansoni
37. Tumour necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon
38. Receptor-mediated monocytoid differentiation of human promyelocytic cells by tumour necrosis factor: Synergistic actions with interferon-γ and 1,25-dihydroxyvitamin D3
39. γ-Interferon enhances macrophage transcription of the tumour necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by repressors
40. Cytokine content in pleural effusion: Comparison between tuberculous and carcinomatous pleurisy
41. Tumour necrosis factor-α (TNF-α) in pleural fluids
42. Interleukin-1β in pleural fluids of different etiologies; its role as inflammatory mediator in empyema
43. The functional relationship of the interleukins
44. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis
45. Identification of a membrane-associated interleukin 1 in macrophages
46. Interleukin 2-mediated immune interferon (IFN-γ) production by human T cells and T cell subsets
47. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4 and tumour necrosis factor
48. Stimulation of antibacterial macrophage activities by B-cell stimulatory factor 2 (interleukin-6)
49. Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis
50. Interleukin-6 production in Mycobacterium bovis BCG-infected mice
51. Human B-cell differentiation factor defined by an antipeptide antibody and its possible role in autoantibody production
52. Interleukin 6 activity in pleural effusion; its diagnostic value and thrombopoetic activity
53. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of IL-10 antibody is associated with enhanced resistance to infection in mice
54. Pleural tuberculosis
55. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: Application of a whole blood cytokine assay in an epidemiological study
56. Reciprocal regulatory effects of IFNγ and IL4 on the in vitro development of human Th1 and Th2 clones
57. Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells
58. IL10 is produced by subsets of human CD4 T cell clones and peripheral blood T cells